Irhythm Technologies Stock Price, News & Analysis (NASDAQ:IRTC)

$62.61 +1.76 (+2.89 %)
(As of 02/20/2018 02:38 AM ET)
Previous Close$62.61
Today's Range$59.72 - $63.70
52-Week Range$32.10 - $66.20
Volume436,143 shs
Average Volume232,972 shs
Market Capitalization$1.44 billion
P/E Ratio-48.16
Dividend YieldN/A
BetaN/A

About Irhythm Technologies (NASDAQ:IRTC)

Irhythm Technologies logoiRhythm Technologies, Inc. is a United States-based digital health company. The Company develops and commercializes solutions that integrate biosensor technology, patient data, analytics and medical expertise. The Company offers flagship solution, the ZIO Service. Its ZIO Service consists of the ZIO XT Patch, algorithms and the ZIO Report. Its myZIO provides a way for patients to enter their symptoms as they occur and on-the-go while wearing the ZIO Patch. Its ZIO Event Card is indicated for use on patients who experience transient symptoms, such as syncope, palpitations, and shortness of breath or dizziness. Its ZIO XT Patch is a non-invasive, water-resistant heart monitor, which prompts high patient compliance and a higher diagnostic yield. Its algorithms analyze the amounts of captured heart beat data and a concise report is provided to the patient’s physician. Its ZIO Report produces a higher diagnostic yield and to change patient management.

Receive IRTC News and Ratings via Email

Sign-up to receive the latest news and ratings for IRTC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Monitoring Systems
Sub-IndustryN/A
SectorHealthcare
SymbolNASDAQ:IRTC
CUSIPN/A
Phone+1-415-6325700

Debt

Debt-to-Equity Ratio0.38%
Current Ratio7.65%
Quick Ratio7.57%

Price-To-Earnings

Trailing P/E Ratio-48.1615384615385
Forward P/E Ratio-40.92
P/E GrowthN/A

Sales & Book Value

Annual Sales$98.51 million
Price / Sales14.61
Cash FlowN/A
Price / CashN/A
Book Value$4.18 per share
Price / Book14.98

Profitability

Trailing EPS($1.30)
Net Income$-29,420,000.00
Net Margins-29.87%
Return on Equity-33.67%
Return on Assets-22.02%

Miscellaneous

Employees406
Outstanding Shares22,980,000

Irhythm Technologies (NASDAQ:IRTC) Frequently Asked Questions

What is Irhythm Technologies' stock symbol?

Irhythm Technologies trades on the NASDAQ under the ticker symbol "IRTC."

How were Irhythm Technologies' earnings last quarter?

Irhythm Technologies Inc (NASDAQ:IRTC) released its earnings results on Wednesday, February, 14th. The company reported ($0.48) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.35) by $0.13. The firm earned $28.20 million during the quarter, compared to analyst estimates of $26.79 million. Irhythm Technologies had a negative return on equity of 33.67% and a negative net margin of 29.87%. The firm's revenue was up 50.8% on a year-over-year basis. During the same quarter last year, the business posted ($0.37) EPS. View Irhythm Technologies' Earnings History.

When will Irhythm Technologies make its next earnings announcement?

Irhythm Technologies is scheduled to release their next quarterly earnings announcement on Wednesday, May, 2nd 2018. View Earnings Estimates for Irhythm Technologies.

Where is Irhythm Technologies' stock going? Where will Irhythm Technologies' stock price be in 2018?

5 brokers have issued 1 year price objectives for Irhythm Technologies' stock. Their predictions range from $59.00 to $79.00. On average, they expect Irhythm Technologies' stock price to reach $67.50 in the next twelve months. View Analyst Ratings for Irhythm Technologies.

What are Wall Street analysts saying about Irhythm Technologies stock?

Here are some recent quotes from research analysts about Irhythm Technologies stock:

  • 1. According to Zacks Investment Research, "iRhythm Technologies, Inc. is a digital healthcare company. It focuses on the provision of ambulatory electrocardiogram, monitoring for patients at risk for arrhythmias primarily in the United States. The company offers ZIO Service, a platform which provides wearable biosensor with cloud-based data analytics that distill data from heartbeats into clinically actionable information. iRhythm Technologies, Inc. is headquartered in San Francisco, California. " (1/3/2018)
  • 2. Canaccord Genuity analysts commented, "We expect these data, assuming the read-out of the full study data follows suit (which we expect), will build IRTC’s case with payers, paving the way ultimately for prospective screening with Zio in a brand new, 3- million-patient TAM. While not in our model at all, we think over time, payors will cover Zio for screening of high-risk patients defined by the mSToPs study. We reiterate our BUY rating and $59 price target." (11/14/2017)

Who are some of Irhythm Technologies' key competitors?

Who are Irhythm Technologies' key executives?

Irhythm Technologies' management team includes the folowing people:

  • Abhijit Y. Talwalkar, Independent Chairman of the Board
  • Kevin M. King, President, Chief Executive Officer, Director (Age 60)
  • Matthew C. Garrett, Chief Financial Officer (Age 49)
  • David A. Vort, Executive Vice President of Sales (Age 51)
  • Derrick Sung Ph.D., Executive Vice President - Strategy and Corporate Development (Age 44)
  • Bruce G. Bodaken, Director (Age 65)
  • Ralph Snyderman M.D., Director (Age 77)
  • Vijay K. Lathi, Independent Director (Age 43)
  • Mark Jeffrey Rubash, Independent Director (Age 60)
  • Raymond W. Scott, Independent Director (Age 70)

When did Irhythm Technologies IPO?

(IRTC) raised $76 million in an initial public offering on Thursday, October 20th 2016. The company issued 5,400,000 shares at $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

Who owns Irhythm Technologies stock?

Irhythm Technologies' stock is owned by many different of institutional and retail investors. Top institutional investors include BlackRock Inc. (6.98%), Franklin Resources Inc. (4.57%), Alliancebernstein L.P. (4.42%), Redmile Group LLC (3.54%), Bank of New York Mellon Corp (3.29%) and TimesSquare Capital Management LLC (2.90%). Company insiders that own Irhythm Technologies stock include David A Vort, Kevin M King, Matthew C Garrett, Raymond W Scott, Synergy Life Science Partners and Vijay K Lathi. View Institutional Ownership Trends for Irhythm Technologies.

Who sold Irhythm Technologies stock? Who is selling Irhythm Technologies stock?

Irhythm Technologies' stock was sold by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, TimesSquare Capital Management LLC, TIAA CREF Investment Management LLC, Pier Capital LLC, Lazard Asset Management LLC, Next Century Growth Investors LLC, Franklin Resources Inc. and Mackenzie Financial Corp. Company insiders that have sold Irhythm Technologies company stock in the last year include David A Vort, Kevin M King, Matthew C Garrett, Raymond W Scott, Synergy Life Science Partners and Vijay K Lathi. View Insider Buying and Selling for Irhythm Technologies.

Who bought Irhythm Technologies stock? Who is buying Irhythm Technologies stock?

Irhythm Technologies' stock was acquired by a variety of institutional investors in the last quarter, including OppenheimerFunds Inc., Citadel Advisors LLC, Redmile Group LLC, BlackRock Inc., Goldman Sachs Group Inc., Brown Capital Management LLC, Perceptive Advisors LLC and Mutual of America Capital Management LLC. View Insider Buying and Selling for Irhythm Technologies.

How do I buy Irhythm Technologies stock?

Shares of Irhythm Technologies can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Irhythm Technologies' stock price today?

One share of Irhythm Technologies stock can currently be purchased for approximately $62.61.

How big of a company is Irhythm Technologies?

Irhythm Technologies has a market capitalization of $1.44 billion and generates $98.51 million in revenue each year. The company earns $-29,420,000.00 in net income (profit) each year or ($1.30) on an earnings per share basis. Irhythm Technologies employs 406 workers across the globe.

How can I contact Irhythm Technologies?

Irhythm Technologies' mailing address is 650 Townsend St Ste 380, SAN FRANCISCO, CA 94103-6248, United States. The company can be reached via phone at +1-415-6325700 or via email at [email protected]


MarketBeat Community Rating for Irhythm Technologies (IRTC)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  83 (Vote Outperform)
Underperform Votes:  86 (Vote Underperform)
Total Votes:  169
MarketBeat's community ratings are surveys of what our community members think about Irhythm Technologies and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Irhythm Technologies (NASDAQ:IRTC) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.802.752.672.75
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $67.50$67.67$62.00$37.75
Price Target Upside: 13.10% upside26.84% upside28.28% upside5.83% upside

Irhythm Technologies (NASDAQ:IRTC) Consensus Price Target History

Price Target History for Irhythm Technologies (NASDAQ:IRTC)

Irhythm Technologies (NASDAQ:IRTC) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/15/2018JPMorgan Chase & Co.Boost Price TargetOverweight -> Overweight$62.00 -> $67.00HighView Rating Details
12/4/2017Royal Bank of CanadaInitiated CoverageOutperform$79.00HighView Rating Details
12/1/2017Dougherty & CoInitiated CoverageNeutral -> NeutralMediumView Rating Details
11/14/2017Canaccord GenuityReiterated RatingBuy$59.00N/AView Rating Details
11/3/2017Morgan StanleyBoost Price TargetOverweight$50.00 -> $65.00N/AView Rating Details
12/6/2016BTIG ResearchDowngradeBuy -> NeutralN/AView Rating Details
(Data available from 2/20/2016 forward)

Earnings

Irhythm Technologies (NASDAQ:IRTC) Earnings History and Estimates Chart

Earnings by Quarter for Irhythm Technologies (NASDAQ:IRTC)

Irhythm Technologies (NASDAQ IRTC) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/2/2018        
2/14/2018Q4 2017($0.35)($0.48)$26.79 million$28.20 millionViewListenView Earnings Details
11/1/2017Q3 2017($0.34)($0.29)$24.30 million$25.04 millionViewN/AView Earnings Details
8/2/2017Q2 2017($0.31)($0.29)$22.10 million$23.85 millionViewListenView Earnings Details
5/3/2017Q1 2017($0.36)($0.24)$19.13 million$21.40 millionViewListenView Earnings Details
2/15/2017Q416($0.28)($0.37)$17.33 million$18.70 millionViewListenView Earnings Details
12/5/2016Q3 2016($0.27)($2.80)$16.52 million$16.80 millionViewListenView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Irhythm Technologies (NASDAQ:IRTC) Earnings Estimates

Current Year EPS Consensus Estimate: $-1.53 EPS
Next Year EPS Consensus Estimate: $-0.94 EPS

Dividends

Dividend History for Irhythm Technologies (NASDAQ:IRTC)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Irhythm Technologies (NASDAQ IRTC) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 23.30%
Institutional Ownership Percentage: 99.18%
Insider Trades by Quarter for Irhythm Technologies (NASDAQ:IRTC)
Insider Trades by Quarter for Irhythm Technologies (NASDAQ:IRTC)

Irhythm Technologies (NASDAQ IRTC) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/5/2018Matthew C GarrettCFOSell42,910$59.17$2,538,984.7036,085View SEC Filing  
12/7/2017Vijay K. LathiDirectorSell150,000$52.57$7,885,500.00View SEC Filing  
12/5/2017Vijay K. LathiDirectorSell57,430$52.41$3,009,906.30View SEC Filing  
12/4/2017Matthew C GarrettCFOSell1,193$55.00$65,615.00View SEC Filing  
11/17/2017Vijay K LathiDirectorSell225,000$52.10$11,722,500.00View SEC Filing  
11/6/2017Kevin M KingInsiderSell60,000$51.85$3,111,000.00103,042View SEC Filing  
9/13/2017Vijay K LathiDirectorSell34,613$49.51$1,713,689.631,405View SEC Filing  
9/12/2017David A. VortEVPSell5,000$48.76$243,800.00View SEC Filing  
9/7/2017Raymond W ScottDirectorSell8,088$48.00$388,224.008,088View SEC Filing  
9/6/2017Raymond W ScottDirectorSell4,661$48.02$223,821.224,661View SEC Filing  
8/28/2017Raymond W ScottDirectorSell12,749$45.30$577,529.7012,749View SEC Filing  
8/7/2017Raymond W. ScottDirectorSell52,903$43.59$2,306,041.77View SEC Filing  
7/11/2017Kevin M. KingInsiderSell110,000$42.08$4,628,800.00View SEC Filing  
7/10/2017Matthew C. GarrettCFOSell25,086$42.06$1,055,117.16View SEC Filing  
6/8/2017Synergy Life Science PartnersMajor ShareholderSell350,000$37.43$13,100,500.00View SEC Filing  
6/8/2017Vijay K LathiDirectorSell430,624$37.59$16,187,156.16View SEC Filing  
5/16/2017Vijay K LathiDirectorSell645,000$34.70$22,381,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Irhythm Technologies (NASDAQ IRTC) News Headlines

Source:
DateHeadline
FY2018 EPS Estimates for Irhythm Technologies Inc Cut by Dougherty & Co (IRTC)FY2018 EPS Estimates for Irhythm Technologies Inc Cut by Dougherty & Co (IRTC)
www.americanbankingnews.com - February 19 at 5:58 AM
Irhythm Technologies Inc (IRTC) Expected to Announce Earnings of -$0.29 Per ShareIrhythm Technologies Inc (IRTC) Expected to Announce Earnings of -$0.29 Per Share
www.americanbankingnews.com - February 15 at 11:10 PM
Irhythm Technologies (IRTC) Stock Rating Reaffirmed by JPMorgan Chase & Co.Irhythm Technologies (IRTC) Stock Rating Reaffirmed by JPMorgan Chase & Co.
www.americanbankingnews.com - February 15 at 11:18 AM
iRhythm Technologies (IRTC) CEO Kevin King on Q4 2017 Results - Earnings Call TranscriptiRhythm Technologies' (IRTC) CEO Kevin King on Q4 2017 Results - Earnings Call Transcript
seekingalpha.com - February 15 at 8:51 AM
Irhythm Technologies (IRTC) Announces Quarterly  Earnings Results, Misses Expectations By $0.13 EPSIrhythm Technologies (IRTC) Announces Quarterly Earnings Results, Misses Expectations By $0.13 EPS
www.americanbankingnews.com - February 14 at 9:12 PM
iRhythm Technologies Announces Fourth Quarter and Full Year 2017 Financial Results and Provides Full Year 2018 Financial OutlookiRhythm Technologies Announces Fourth Quarter and Full Year 2017 Financial Results and Provides Full Year 2018 Financial Outlook
finance.yahoo.com - February 14 at 4:42 PM
Irhythm Technologies Inc (IRTC) Given Consensus Recommendation of "Hold" by BrokeragesIrhythm Technologies Inc (IRTC) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - February 14 at 10:38 AM
iRhythm Technologies to Present at the RBC Global Healthcare ConferenceiRhythm Technologies to Present at the RBC Global Healthcare Conference
finance.yahoo.com - February 8 at 9:00 AM
Irhythm Technologies (IRTC) Set to Announce Earnings on WednesdayIrhythm Technologies (IRTC) Set to Announce Earnings on Wednesday
www.americanbankingnews.com - February 7 at 4:38 AM
iRhythm Technologies to Report Fourth Quarter and 2017 Financial Results on February 14, 2018iRhythm Technologies to Report Fourth Quarter and 2017 Financial Results on February 14, 2018
finance.yahoo.com - January 31 at 4:34 PM
Irhythm Technologies (IRTC) Stock Rating Lowered by BidaskClubIrhythm Technologies (IRTC) Stock Rating Lowered by BidaskClub
www.americanbankingnews.com - January 27 at 9:04 AM
Irhythm Technologies Inc (IRTC) Given Average Recommendation of "Hold" by BrokeragesIrhythm Technologies Inc (IRTC) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - January 20 at 7:34 AM
Insider Selling: Irhythm Technologies Inc (IRTC) CFO Sells 42,910 Shares of StockInsider Selling: Irhythm Technologies Inc (IRTC) CFO Sells 42,910 Shares of Stock
www.americanbankingnews.com - January 9 at 12:46 AM
Irhythm Technologies (IRTC) Upgraded at BidaskClubIrhythm Technologies (IRTC) Upgraded at BidaskClub
www.americanbankingnews.com - January 6 at 11:08 AM
ETFs with exposure to iRhythm Technologies, Inc. : January 1, 2018ETFs with exposure to iRhythm Technologies, Inc. : January 1, 2018
finance.yahoo.com - January 1 at 4:12 PM
iRhythm Technologies, Inc. is trading above its 50 day moving average : IRTC-US : December 28, 2017iRhythm Technologies, Inc. is trading above its 50 day moving average : IRTC-US : December 28, 2017
finance.yahoo.com - December 28 at 1:06 PM
Irhythm Technologies Inc (IRTC) Receives Average Rating of "Hold" from AnalystsIrhythm Technologies Inc (IRTC) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - December 26 at 7:54 AM
iRhythm Technologies, Inc. :IRTC-US: Earnings Analysis: Q3, 2017 By the Numbers : December 25, 2017iRhythm Technologies, Inc. :IRTC-US: Earnings Analysis: Q3, 2017 By the Numbers : December 25, 2017
finance.yahoo.com - December 25 at 5:17 PM
ETFs with exposure to iRhythm Technologies, Inc. : December 21, 2017ETFs with exposure to iRhythm Technologies, Inc. : December 21, 2017
finance.yahoo.com - December 21 at 4:18 PM
iRhythm Technologies to Present at the J.P. Morgan 36th Annual Healthcare ConferenceiRhythm Technologies to Present at the J.P. Morgan 36th Annual Healthcare Conference
finance.yahoo.com - December 21 at 4:18 PM
Irhythm Technologies (IRTC) Lowered to "Sell" at BidaskClubIrhythm Technologies (IRTC) Lowered to "Sell" at BidaskClub
www.americanbankingnews.com - December 17 at 12:50 AM
Vijay K. Lathi Sells 57,430 Shares of Irhythm Technologies Inc (IRTC) StockVijay K. Lathi Sells 57,430 Shares of Irhythm Technologies Inc (IRTC) Stock
www.americanbankingnews.com - December 7 at 8:39 PM
Irhythm Technologies Inc (IRTC) Director Sells $7,885,500.00 in StockIrhythm Technologies Inc (IRTC) Director Sells $7,885,500.00 in Stock
www.americanbankingnews.com - December 7 at 8:39 PM
iRhythm Technologies, Inc. breached its 50 day moving average in a Bearish Manner : IRTC-US : December 7, 2017iRhythm Technologies, Inc. breached its 50 day moving average in a Bearish Manner : IRTC-US : December 7, 2017
finance.yahoo.com - December 7 at 11:08 AM
Insider Selling: Irhythm Technologies Inc (IRTC) CFO Sells 1,193 Shares of StockInsider Selling: Irhythm Technologies Inc (IRTC) CFO Sells 1,193 Shares of Stock
www.americanbankingnews.com - December 5 at 7:34 PM
Irhythm Technologies (IRTC) Earns Outperform Rating from Royal Bank Of CanadaIrhythm Technologies (IRTC) Earns Outperform Rating from Royal Bank Of Canada
www.americanbankingnews.com - December 4 at 8:06 AM
Dougherty & Co Initiates Coverage on Irhythm Technologies (IRTC)Dougherty & Co Initiates Coverage on Irhythm Technologies (IRTC)
www.americanbankingnews.com - December 1 at 6:58 PM
Insider Selling: Irhythm Tech (IRTC) Director Sells 225,000 Shares of StockInsider Selling: Irhythm Tech (IRTC) Director Sells 225,000 Shares of Stock
www.americanbankingnews.com - November 20 at 7:36 PM
Canaccord Genuity Reiterates Buy Rating for Irhythm Tech (IRTC)Canaccord Genuity Reiterates Buy Rating for Irhythm Tech (IRTC)
www.americanbankingnews.com - November 14 at 11:03 PM
iRhythm Technologies, Inc. breached its 50 day moving average in a Bearish Manner : IRTC-US : November 9, 2017iRhythm Technologies, Inc. breached its 50 day moving average in a Bearish Manner : IRTC-US : November 9, 2017
finance.yahoo.com - November 11 at 1:28 PM
iRhythm Technologies, Inc. – Value Analysis (NASDAQ:IRTC) : November 10, 2017iRhythm Technologies, Inc. – Value Analysis (NASDAQ:IRTC) : November 10, 2017
finance.yahoo.com - November 11 at 1:28 PM
Irhythm Tech (IRTC) Insider Sells $3,111,000.00 in StockIrhythm Tech (IRTC) Insider Sells $3,111,000.00 in Stock
www.americanbankingnews.com - November 8 at 12:40 PM
ETFs with exposure to iRhythm Technologies, Inc. : November 6, 2017ETFs with exposure to iRhythm Technologies, Inc. : November 6, 2017
finance.yahoo.com - November 7 at 4:55 AM
IRHYTHM TECH (IRTC) Price Target Raised to $65.00 at Morgan StanleyIRHYTHM TECH (IRTC) Price Target Raised to $65.00 at Morgan Stanley
www.americanbankingnews.com - November 5 at 10:18 AM
Irhythm Tech (IRTC) PT Raised to $59.00 at Canaccord GenuityIrhythm Tech (IRTC) PT Raised to $59.00 at Canaccord Genuity
www.americanbankingnews.com - November 2 at 9:48 PM
iRhythm Technologies, Inc. to Host Earnings CalliRhythm Technologies, Inc. to Host Earnings Call
finance.yahoo.com - November 2 at 2:47 AM
iRhythm Technologies Announces Third Quarter 2017 Financial Results and Raises Guidance for Full Year 2017iRhythm Technologies Announces Third Quarter 2017 Financial Results and Raises Guidance for Full Year 2017
finance.yahoo.com - November 2 at 2:47 AM
Irhythm Tech (IRTC) Posts  Earnings Results, Beats Expectations By $0.05 EPSIrhythm Tech (IRTC) Posts Earnings Results, Beats Expectations By $0.05 EPS
www.americanbankingnews.com - November 1 at 6:38 PM
ETFs with exposure to iRhythm Technologies, Inc. : October 27, 2017ETFs with exposure to iRhythm Technologies, Inc. : October 27, 2017
finance.yahoo.com - October 28 at 7:10 AM
Irhythm Tech (IRTC) to Release Earnings on WednesdayIrhythm Tech (IRTC) to Release Earnings on Wednesday
www.americanbankingnews.com - October 25 at 10:30 AM
IRHYTHM TECH (IRTC) Rating Increased to Hold at ValuEngineIRHYTHM TECH (IRTC) Rating Increased to Hold at ValuEngine
www.americanbankingnews.com - October 21 at 10:40 AM
Irhythm Tech (IRTC) Given Consensus Rating of "Buy" by BrokeragesIrhythm Tech (IRTC) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - October 21 at 3:04 AM
iRhythm Technologies to Report Third Quarter 2017 Financial Results on November 1, 2017iRhythm Technologies to Report Third Quarter 2017 Financial Results on November 1, 2017
finance.yahoo.com - October 18 at 4:48 PM
ETFs with exposure to iRhythm Technologies, Inc. : October 17, 2017ETFs with exposure to iRhythm Technologies, Inc. : October 17, 2017
finance.yahoo.com - October 18 at 2:29 AM
Say Goodbye To Your Smartphone: The Wearables Future Has ArrivedSay Goodbye To Your Smartphone: The Wearables Future Has Arrived
seekingalpha.com - October 17 at 12:32 AM
Brokerages Anticipate Irhythm Tech (IRTC) to Post ($0.34) Earnings Per ShareBrokerages Anticipate Irhythm Tech (IRTC) to Post ($0.34) Earnings Per Share
www.americanbankingnews.com - October 13 at 6:44 AM
ETFs with exposure to iRhythm Technologies, Inc. : October 6, 2017ETFs with exposure to iRhythm Technologies, Inc. : October 6, 2017
finance.yahoo.com - October 6 at 11:55 PM
iRhythm Technologies, Inc. :IRTC-US: Earnings Analysis: Q2, 2017 By the Numbers : October 5, 2017iRhythm Technologies, Inc. :IRTC-US: Earnings Analysis: Q2, 2017 By the Numbers : October 5, 2017
finance.yahoo.com - October 6 at 1:11 AM
Irhythm Tech (IRTC) Price Target Raised to $55.00 at Canaccord GenuityIrhythm Tech (IRTC) Price Target Raised to $55.00 at Canaccord Genuity
www.americanbankingnews.com - September 22 at 8:47 AM
Irhythm Tech (IRTC) Director Vijay K. Lathi Sells 34,613 SharesIrhythm Tech (IRTC) Director Vijay K. Lathi Sells 34,613 Shares
www.americanbankingnews.com - September 15 at 4:30 PM

SEC Filings

Irhythm Technologies (NASDAQ:IRTC) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Irhythm Technologies (NASDAQ:IRTC) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Irhythm Technologies (NASDAQ IRTC) Stock Chart for Tuesday, February, 20, 2018

Loading chart…

This page was last updated on 2/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.